ÂsÄý³æ­Ó¤å³¹
¤pÃa³J
Elite Member
 
¤pÃa³Jªº¤jÀY·Ó
 

¥[¤J¤é´Á: Dec 2003
±zªº¦í§}: °°¤jÄG¤l¦B¤HXD
¤å³¹: 7,327
§@ªÌ nightcatman (©]¿ß) ¬ÝªO Gossiping
¼ÐÃD ¤T»EÙæÓi¨Æ¥ó§Þ³N¦Wµü¾ã²z
®É¶¡ Thu Sep 25 10:50:26 2008
¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w¢w

ªá¤F´X­Ó¤p®É²×©óª¦§¹¤F¤j³¡¥÷ªº¤T»EÙæÓi°Q½×¦ê
¤]¬Ý¤FFDA©M¼Ú·ùªº­ì¤å
µo²{ª©¤Wªº°Q½×¥æÂø¦UºØ¿ù»~©M¥¿½TªºÆ[©À
©Ò¥H¤~·Q¨ì­nµo½g³o¤å

²@µLºÃ°Ýªº, ³o¦¸½Ã¥Í¸pªº³B¸m½T¦³¤£·í
¦ý§Ú·Q«ü¥X¥L­Ì¯u¥¿¿ù»~ªº¦a¤è¬O«Ü­«­nªº
§_«h¦UºØ¦ü¬O¦Ó«Dªºª§½×ÁÙ·|Ä~Äò¤U¥h

­º¥ý§Ú·|¥ýÂç²M¤@¨Ç¦Wµü¤Î©M·§©À
µM«á¸ÑÄÀ¤@¤UFDA©M¼Ú·ùªº­ì¤å¬O¦bÁ¿¤°»ò
³Ì«á¤~¬O­Ó¤H¹ï³o¾ã¥ó¨Æªº¬Ýªk

±µ¤U¨Ó¬O¥¿¤å

(1) ppm: §Ú·Q³o­Ó¤j®a¤ñ¸û²M·¡, ppm´N¬Oparts per millionªºÁY¼g
¤]´N¬O¦Ê¸U¤À¤§¤@, ¦ý³o¨Ã¤£­­©óÅé¿n¤W©Î­«¶q¤W, ¦]¦¹«e­±
¦³¤H»¡¥¤¯»¬O©TÅé¨S¿ìªk´úppm, ¨Æ¹ê¤W¨Ã«D¦p¦¹, ½Ã¥Í¸p³W½d
¤¤©ÒºÙªºppm³æ¯Â¬O«ü¥¤¯»(©TÅé)Á`­«¶q©M©Ò§tªº¤T»EÙæÓi­«¶q
ªº¤ñ¨Ò¦Ó¤w, ¥Î©w¶qªº¥¤¯»ªw¤ô«á¦A¥h´ú¤T»EÙæÓi§t¶q, ¤@¼Ë
¥i¥H±o¨ì©M½Ã¥Í¸p³W½d©w¸q¤@­Pªºppm

(2) ¤T»EÙæÓiªº¶q´ú:

¤@¯ë¬O¥ÎGC©ÎHPLC¨Ó´ú, «e­±¦³ª§½×¨ì©³²{¦æ¶q´úªººë½T«×¨ì­þ,
¦bFDA¤å¥ó¤¤, ³Ì§C°»´ú·¥­­(lower limit of detection, LOD)
¥i¥H§C¨ì10ppb, ¦ý¨º¬O³Ì¨Î¼Æ­È, ¤@¯ë±¡ªp¤ULOD¬ù¦b50~100ppb
, ¦¹¼Æ­È³QFDA©M¼Ú·ù³£±Ä¥Î, ¦b¦¹¤§¤Uªº¶q´ú­È´Nºâ¬O¦³, ¤]·|
³Qµø¬°¬O¹s, ¦]¦¹«e­±¦³¤H»¡½Ã¥Í¸p©Ò­qªº2.5ppm¬O¶q´ú·¥­­ªº
»¡ªk, ¨Ã¤£¦¨¥ß, ¯u¥¿ªº¶q´ú·¥­­»·§C©ó¦¹

ªþ±a¤@´£, Áp¦X³ø¦³·s»D»¡¬Y¾ÇªÌÁnºÙFDA¹ï¤T»EÙæÓiªº¼Ð·Ç¬O
50ppb, ¸Ó¾ÇªÌ¤Þ¥Îªº´N¬O³o­Ó¼Æ¦r, ¤£¹L¥L³o¬O¶Ã®M¼Æ¾Ú, LOD
©M­­¨î¼Ð·Ç®Ú¥»¬O¨â¦^¨Æ

(3) Tolerable Daily Intake (TDI):

³oÀ³¸Ó¬O³Ì³Q»~¸Ñªº¼Æ­È¤F, ­º¥ý§Ú­Ì¥²¶·¥ý¤F¸Ñ, TDI¬O¥Î¦b
"¤£¸Ó¦s¦b©ó­¹«~¤¤" ªºª«½èªº, Acceptable Daily Intake
(ADI) ¤~¬O¥Î¦b­¹«~²K¥[ª«¤Wªº, ¦]¦¹¬Ý¨ìTDI, ´Nªí¥Ü¤F¸Óª«½è
µ´¹ï¤£¸Ó³Qµø¬°¬O­¹«~²K¥[ª«, ¦ÓÀ³¸Ó³Qµø¬°¬O¦³®`ª«½è

¥Ñ©ó¬OTDI¬O¹ï¦³®`ª«½è¦Ó¤£¬O­¹ª«, ©Ò¥H°ò©ó¹D¼w¦]¯À, ¤HÅé
¹êÅç¬O¤£¥i¯àªº, ¥u¯à°µ°Êª«¹êÅç, ¦]¦¹«e­±¦³¤H½èºÃFDA¤å¥ó
ùتºTDI¨S¦³°µ¤HÅé¸ÕÅç, ³o¬O§¹¥þnonsenseªº½èºÃ

¦ÓTDI¬O¥ÑNOAEL (no-observed-adverse-effect-levels)±o¨Ó,
¦p¦r­±©Ò­z, NOAEL§Y¬O¦b¹êÅ礤¨S¦³Æ[¹î¨ì¥ô¦ó­t­±²{¶Hªº¾¯¶q
¤W­­, ³o©MLD50¤£¦P, ¤£¬O¦º¤F¤~ºâ¦Ó¬O¥u­n¦³¥ô¦ó²§±`³£ºâ,
©Ò¥H«e­±¦³¤H½èºÃTDI¥u¯à¤ÏÀ³­P¦º²v¦Ó¤£¯à¤ÏÀ³­P¯f²v, ³o¤@¼Ë
¬Ononsenseªº½èºÃ

¦bFDAªº¤å¥ó¤¤, ¤T»EÙæÓiªºNOAEL¬O 63 mg/kg bw/day, ³o­Ó¼Æ
­È¥²¶·¦A°£¥H10¥H®e³\ª«ºØ®t²§ªº­·ÀI(¦]¬°°µªº¬O°Êª«¹êÅç),
µM«á¦A°£¥H10¥H®e³\­ÓÅé®t²§ªº­·ÀI, ³oºÙ¬° safety/uncertainty
factors (SF/UF), ³Ì«á©Ò±o¨ìªº 0.63 mg/kg bw/day ´N¬OTDI,
©Ò¥H«e­±¦³¤H½èºÃ¦Ñ¹«¹êÅ礣¯à®M¥Î¨ì¤H¨­¤W, ¦ý³o­·ÀI¨ä¹ê¤w¸g
¦bTDIªº­pºâ¹Lµ{ùØ­±³Q¦ô­p¶i¥h¤F

¯u¥¿¸Ó½èºÃªºÂI¬O¦~ÄÖ°ÝÃD, ¹ïÀ¦¥®¨à¦Ó¨¥, TDIÀ³¸Ó¦A¤U­°,
¬Æ¦Ü¥i¤U­°10­¿³£¤£¬°¹L
(4) FDAªº¤å¥ó:

­ì¤å¦b
http://www.cfsan.fda.gov/~dms/melamra.html

«Ü¦h¤H»~¸Ñ¤F³o¤å¥óªº¥Øªº, ³o¤å¥ó¨Ã¤£¬O­n­q¤@­Ó­¹«~¼Ð·Ç,
¦Ó¬O¥Ñ©ó·í¦~¦³«Ü¦h§t¤T»EÙæÓiªº¤¤°ê»sÃdª«­¹«~¤Î¹}®Æ¶i¨ì¬ü°ê,
¦]¦¹¬ü°ê§Æ±æª¾¹D¥¦¦b½Þ¦×,Âû¦×,³½¦×,³JÃþ¤¤ªº´Ý¯d¶q¬O§_·|
¦³¦w¥þ¤WªºÅU¼{, ­º¥ý¥L­Ì°µ¤F°Êª«¹êÅç¥h¦ô­pTDI, µM«á¶q´ú¦b
¦UºØ­¹ª«¤ºªº¤T»EÙæÓi´Ý¯d¶q, ±µµÛ³]­p¤F¤TºØ±¡¹Ò¥h¦ôºâ¤HÅé
ªº¤T»EÙæÓiÄá¨ú¶q, ¨Ã¥B©MTDI¤ñ¸û, µ²ªGÅã¥Ü§Y¨Ï¦b³ÌÃaªº±¡ªp
¤U (Scenario 3, Worst case), ¤HÅéÄá¨ú¶q¤´Â»·§C©óTDI¨â­Ó
¼Æ¶q¯Å¥H¤W

(5) ¼Ú·ùªº¤å¥ó:

­ì¤å¦b
http://www.efsa.eu.int/cs/BlobServe...f?ssbinary=true

¼Ú·ùªºEFSA©MFDA°µ³o¤å¥óªº²z¥Ñ¤@¼Ë, ³£¬O¬°¤F­n¦]À³§t¤T»E
ÙæÓiªº¤¤°ê»sÃdª«­¹«~¤Î¹}®Æªº¶i¤f, ¦ý¤£¦Pªº¬OEFSA¨Ã¨S¦³¥h
°µ¥ô¦óªº¹êÅç, ¦Ó¬O¥hreview¤F¤j¶qªº¬ã¨s¤åÄm¨Ó§@§PÂ_, ¦Ó
¥Ñ©óScientific Committee of Food (SCF)¦b¤§«e¹ï©ó²±¸Ë­¹ª«
ªºª«½è¦³¤@­Ó 0.5 mg/kg bw/dayªºTDI, ¦Ó¦¹¼Æ­È¤S¤ñFDAªº§ó¤p
, ©Ò¥HEFSA«ØÄ³¼Ú·ù¦U°ê¥ç¤Þ¥Î¦¹¼Æ­È°µ¬°¹ï­¹ª«¤Î¹}®ÆªºTDI

(6) ª©¤Wªº°Q½×¤Î­Ó¤H¬Ýªk:

­º¥ý¤£¯à¤£´£¨ìªº´N¬O¬Y¨Ç¤å¤¤¹ï©óppm©MTDIªº­pºâ, ¦b¨º¨Ç¤å
¤¤¥H½Ã¥Í¸p©Ò­q¼Ð·Çªº2.5ppm¨Ó­pºâ¥¤¯»¤¤ªº¤T»EÙæÓi§t¶q, µM«á
»P¬ü°ê©Î¼Ú·ùªºTDI¤ñ¸û, ¨ÓÃÒ©ú½Ã¥Í¸p©Ò­qªº¼Ð·Ç¬O¦X²zªº

§Ú­n»¡ªº¬O, ¦b¼Æ¦r¤W, ¨º¨Ç¤å¤¤ªº­pºâ¬O¥¿½Tªº, ·Ó³o¼Ëºâ¥X
¨ÓªºÄá¨ú¶q½T¹ê»·§C©óTDI, ¦ý¬O¦b·§©À¤W, ¥Î³o¼Ëªº­pºâµ²ªG¥h
±À½×½Ã¥Í¸p©Ò­qªº¼Ð·Ç¬O¦X²zªº«oµLªk¦¨¥ß, ­ì¦]¦p¤U:

¥Ñ«e­z, ¤T»EÙæÓiÀ³¬O¦³®`ª«½è¦Ó¤£¬O­¹«~²K¥[ª«, ¦]¦¹¤~·|
¥ÎTDI¦Ó¤£¬OADI, ¦Ó¹ï©ó¨âªÌªººÞ²zÅÞ¿è¬O§¹¥þ¤£¦Pªº, ¹ï©ó
­¹«~²K¥[ª«¦Ó¨¥, ¥i¥H®ø·¥ªº±NADI­q¬°¦w¥þªº¤W­­, ¥u­n¤£¶W¹L
³o­Ó¼Ð·Ç´N®e³\²K¥[, ¦ý¬O¹ï©ó¦³®`ª«½è¦Ó¨¥, TDIÀ³¸Ó¿n·¥ªº
°µ¬°Äµ§Ùªº¤U­­, ¤]´N¬O»¡¦Ü¤Ö­nĵ§Ù¨ìTDIªºµ{«×, ¦ý¨Ã¤£­­©ó
ĵ§Ù¨ìTDIªºµ{«×´Nºâ¤F, ¨ä¼Ð·ÇÀ³¸Ó­n§C©óTDI¥B¶VÄY¶V¦n, ª½¨ì
¹Gªñ¨ìÀô¹Ò¤£¥iÁ×§Kªºµ{«× (¨Ò¦p®e¾¹ªº¬ªº|©Î°Êª«Å餺ªº´Ý¦s)

¦ý«ÜÅãµMªº, ½Ã¥Í¸pªº2.5ppm¨Ã¤£¬O¨Ì³o¼ËªºÅÞ¿è¨Ó³]©wªº,
¥¦¨Ã¨S¦³ºÉ¤O¥h¹Gªñ¨ìÀô¹Ò¤£¥iÁ×§Kªº³ÌÄY®æµ{«×, ¤]¦]¦¹µLªk
¯u¥¿±Æ°£¤H¬°²K¥[ªº¥i¯à©Ê, ¦Ó³o´N¬O½Ã¥Í¸p³Ì¤jªº¿ù»~©Ò¦b --
¥¦§â¤@­Ó¦³®`ª«½è¥Î­¹«~²K¥[ª«ªºÅÞ¿è¨ÓºÞ²z, ¦P®É³o¤]¬O«e­z
­pºâ¤åªºª¼ÂI©Ò¦b, ºâ¥X¨Óªº¼Æ¦r§C©óTDI, ¨Ã¤£¥Nªí³o­Ó¼Ð·Ç
´N¬O¦X²zªº, ¦]¬°¨º¬OTDI¦Ó¤£¬OADI


¥H¤W´N¬O§Ú­Ó¤H¹ï¦¹¨Æªº¬Ýªk


½Ð¤£§[«ü±Ð ÁÂÁÂ

---------

³o½g¤£¿ù
__________________
³o¦~ÀY¡A°Q½×°Ï°Ó®a¤ñª±®a¦h¡F¥~¦æ¤ñ¤º¦æ§ó¦³»¡ªA¤O¡F²Ê»sÄê³yªº¸­¯\¶²¤ñ¥Î¤ß¼gªº´ú¸Õ¤å§ó¦h¦^À³
¶}©l¾ÇµÛ¦h¥h¸Ñ¨M¨ä¥L¤Hªº°ÝÃD¨Ó¨ú¥N¼L¬¶¡A´N·í§@¬O¤@ºØ¦^õX§a!
ÁÙ¦b©ê«è¬°Ô£¨S¦³·sªº¤å³¹¨S¦³¦nªº¤º®e¡A¦ó¤£·Q·Q¦Û¤v°^Äm¤F¤°»ò¡H
¦A¨£!«¥­Ì¹Ú¸Ì¨£

PS¡G§AÁÙ¦b¶RÂû±Æ©±ªº²£«~¶Ü....½Ð¸C¤j²´¬Ý²M·¡¡A¥H§K¦¨¬°¤U¤@­Ó¨üÄFªº¹ï¶H
ÂÂ 2008-09-25, 11:53 AM #234
¦^À³®É¤Þ¥Î¦¹¤å³¹
¤pÃa³JÂ÷½u¤¤